Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $5.78M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Actinium Pharmaceuticals USD 5.78M 1.72M Sep/2025
Amgen USD 5.9B 773M Dec/2025
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025